Natus Neurology has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Health Canada clearance for its new electrodiagnostic system, the UltraPro S100 EMG system.
The UltraPro S100 is an EMG/nerve conduction device intended for monitoring and testing electrophysiologic and electrodiagnostic information from the human nervous and muscular system.
The UltraPro S100 which is built on the 60-year heritage of Nicolet, Dantec, XLTEK and Teca brands features easy-to-use reports, efficient connectivity to electronic medical records, distinctive function keys, online summaries and a built-in reference value database.
The new device offers reliability, performance, portability and exceptional value to the US and Canadian clinicians.
Natus Medical vice president and general manager Austin Noll noted the company is excited to bring the new UltraPro S100 EMG System to the U.S. & Canadian markets.
"The UltraPro S100 helps strengthen our market-leading EMG portfolio and ensures clinicians and patients can benefit from the latest advancements in neurological care," Noll added.
The UltraPro S100 developed in close cooperation with physicians and technologists helps improve workflow in busy clinical settings by effectively organizing data into a variety of automated reporting formats.
This new system allows clinicians to complete their studies and generate reports with ease, streamlines workflow, improves efficiency and lowers costs.
The UltraPro S100 EMG System is currently available to order and ship in the US and Canada.